Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.

However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. All that said, here are three stocks getting more buzz than they deserve and some you should buy instead.

GMS (GMS)

One-Month Return: +38.3%

Founded in 1971, GMS (NYSE: GMS) distributes specialty building materials including wallboard, ceilings, and insulation products, to the construction industry.

Why Do We Think Twice About GMS?

1. Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
2. Demand will likely fall over the next 12 months as Wall Street expects flat revenue
3. Earnings per share have contracted by 18.1% annually over the last two years, a headwind for returns as stock prices often echo long-term EPS performance

GMS’s stock price of $109.53 implies a valuation ratio of 17.8x forward P/E. Read our free research report to see why you should think twice about including GMS in your portfolio.

Avis Budget Group (CAR)

One-Month Return: +40.5%

The parent company of brands such as Zipcar and Budget Truck Rental, Avis (NASDAQ: CAR) is a provider of car rental and mobility solutions.

Why Do We Steer Clear of CAR?

1. Performance surrounding its available rental days - car rental has lagged its peers
2. Diminishing returns on capital suggest its earlier profit pools are drying up
3. Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution

Avis Budget Group is trading at $177.20 per share, or 5.6x forward EV-to-EBITDA. If you’re considering CAR for your portfolio, see our FREE research report to learn more.

Owens & Minor (OMI)

One-Month Return: +9.2%

With roots dating back to 1882 and operations spanning approximately 80 countries, Owens & Minor (NYSE: OMI) is a healthcare solutions company that manufactures medical supplies, distributes products to healthcare providers, and delivers medical equipment directly to patients.

Why Does OMI Fall Short?

1. Scale is a double-edged sword because it limits the company’s growth potential compared to its smaller competitors, as reflected in its below-average annual revenue increases of 3.2% for the last two years
2. Underwhelming 3.8% return on capital reflects management’s difficulties in finding profitable growth opportunities, and its falling returns suggest its earlier profit pools are drying up
3. Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

At $8.66 per share, Owens & Minor trades at 4.8x forward P/E. To fully understand why you should be careful with OMI, check out our full research report (it’s free).

Stocks We Like More

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today